Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/crispr.2018.29022.pro | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Aerosol particles released from grit chambers of nine urban wastewater treatment plants in typical regions: Fugitive characteristics, quantitative drivers, and generation process.
Water Res
January 2025
State Key Laboratory of Environmental Aquatic Chemistry, Research Center for Eco- Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address:
The flow through the grit chamber is non-biochemically treated wastewater, which contains microorganisms mainly from the source of wastewater generation. There are limited reports on aerosol particles generated by grit chambers compared with those produced by biochemical treatment tanks. This study analyzed the fugitive characteristics of aerosol particles produced in grit chambers at nine wastewater treatment plants in three regions of China.
View Article and Find Full Text PDFDifferent fates between extracellular and intracellular antimicrobial resistome in full-scale activated sludge and membrane bioreactor processes.
Water Res
January 2025
Faculty of Geosciences and Civil Engineering, Kanazawa University, Kanazawa 920-1192, Japan; Center for Infectious Disease Education and Research (CiDER), Osaka University, 565-0871, Japan. Electronic address:
Treated effluent of wastewater treatment plants (WWTPs) are major sources of extracellular antimicrobial resistance genes (eARGs) into aquatic environments. This study aimed to clarify the fate and origins of eARGs from influent to treated effluent at a full-scale WWTP. The compositions of eARG and intracellular ARG (iARG) were acquired via shotgun metagenomic sequencing in influent wastewater, activated sludge, and treated effluent of the target WWTP, where identical wastewater was treated by conventional activated sludge (CAS) and membrane bioreactor (MBR) processes.
View Article and Find Full Text PDFSolvent-modulated preparation of lead-free CsBiIpolycrystalline film for high-performance photodetectors.
Nanotechnology
January 2025
School of Instrumentation Science and Opto-electronics Engineering, Beijing Information Science and Technology University, 12 Qinghe Xiaoying East Road, Xisanqi Street, Haidian District, Beijing, Beijing, 100192, CHINA.
Lead-free cesium bismuth iodide (CsBiI) perovskite exhibits extraordinary optoelectronic properties and attractive potential in various optoelectronic devices, especially the application for photodetectors. However, most CsBiIphotodetectors demonstrated poor detection performance due to the difficulty in obtaining high-quality polycrystalline films. Therefore, it makes sense to modulate the preparation of high-quality CsBiIpolycrystalline films and expand its applications.
View Article and Find Full Text PDFAutomated detection of traumatic bleeding in CT images using 3D U-Net# and multi-organ segmentation.
Biomed Phys Eng Express
January 2025
Chiba University Center for Frontier Medical Engineering, 1-33 Yayoi-cho, Inage-ku, Chiba, Chiba, 263-8522, JAPAN.
Traumatic injury remains a leading cause of death worldwide, with traumatic bleeding being one of its most critical and fatal consequences. The use of whole-body computed tomography (WBCT) in trauma management has rapidly expanded. However, interpreting WBCT images within the limited time available before treatment is particularly challenging for acute care physicians.
View Article and Find Full Text PDFEffectiveness of regorafenib in second-line therapy for advanced hepatocellular carcinoma: A systematic review and meta-analysis.
Medicine (Baltimore)
January 2025
Department of Hepatobiliary Surgery, The Third Central Hospital of Tianjin, Tianjin, China.
Background: In patients with advanced hepatocellular carcinoma (HCC) following sorafenib failure, regorafenib has been used as an initial second-line drug. It is unclear the real efficacy and safety of sorafenib-regorafenib sequential therapy compared to placebo or other treatment (cabozantinib or nivolumab or placebo) in advanced HCC.
Methods: Four electronic databases (PubMed, Embase, Web of Science, and Ovid) were systematically searched for eligible articles from their inception to July, 2024.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!